Search details
1.
Glycolytic metabolism of pathogenic T cells enables early detection of GVHD by 13C-MRI.
Blood
; 137(1): 126-137, 2021 01 07.
Article
in English
| MEDLINE | ID: mdl-32785680
2.
A randomized phase 2 trial of pomalidomide in subjects failing prior therapy for chronic graft-versus-host disease.
Blood
; 137(7): 896-907, 2021 02 18.
Article
in English
| MEDLINE | ID: mdl-32976576
3.
Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study.
Blood
; 138(22): 2278-2289, 2021 12 02.
Article
in English
| MEDLINE | ID: mdl-34265047
4.
Meaningful response criteria for myelodysplastic syndromes.
Br J Haematol
; 196(5): 1137-1148, 2022 03.
Article
in English
| MEDLINE | ID: mdl-34628648
5.
The clinical landscape of chronic graft-versus-host disease management in 2021.
Br J Haematol
; 196(4): 830-848, 2022 02.
Article
in English
| MEDLINE | ID: mdl-34599519
6.
Collection of peripheral blood mononucleated cells for chronic graft-versus-host disease immunology research: safety and effectiveness of leukapheresis in 132 patients.
J Transl Med
; 20(1): 519, 2022 11 08.
Article
in English
| MEDLINE | ID: mdl-36348353
7.
Long-term follow-up after lymphodepleting autologous haematopoietic cell transplantation for treatment-resistant systemic lupus erythematosus.
Rheumatology (Oxford)
; 61(8): 3317-3328, 2022 08 03.
Article
in English
| MEDLINE | ID: mdl-34875023
8.
CD69+ resident memory T cells are associated with graft-versus-host disease in intestinal transplantation.
Am J Transplant
; 21(5): 1878-1892, 2021 05.
Article
in English
| MEDLINE | ID: mdl-33226726
9.
Rehabilitation Interventions in the Multidisciplinary Management of Patients With Sclerotic Graft-Versus-Host Disease of the Skin and Fascia.
Arch Phys Med Rehabil
; 102(4): 776-788, 2021 04.
Article
in English
| MEDLINE | ID: mdl-33347890
10.
B regulatory cells and monocyte subpopulations in patients with chronic graft-vs-host disease.
Croat Med J
; 62(2): 154-164, 2021 Apr 30.
Article
in English
| MEDLINE | ID: mdl-33938655
11.
A New Standard in Graft-versus-Host Disease Prophylaxis? An Introduction to Blood and Marrow Transplant Clinical Trials Network 1703.
Biol Blood Marrow Transplant
; 26(12): e305-e308, 2020 12.
Article
in English
| MEDLINE | ID: mdl-32920205
12.
Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide.
Biol Blood Marrow Transplant
; 26(8): 1459-1468, 2020 08.
Article
in English
| MEDLINE | ID: mdl-32434056
13.
W"H-Y" antigen/HLA complexes in chronic GVHD.
Blood
; 142(11): 946-948, 2023 09 14.
Article
in English
| MEDLINE | ID: mdl-37707875
14.
Introduction to a review series on emerging immunotherapies for hematologic diseases.
Blood
; 131(24): 2617-2620, 2018 06 14.
Article
in English
| MEDLINE | ID: mdl-29728405
15.
Clinical characteristics and cytokine biomarkers in patients with chronic graft-vs-host disease persisting seven or more years after diagnosis.
Am J Hematol
; 95(4): 387-394, 2020 04.
Article
in English
| MEDLINE | ID: mdl-31903638
16.
Motor ability, function, and health-related quality of life as correlates of symptom burden in patients with sclerotic chronic graft-versus-host disease receiving imatinib mesylate.
Support Care Cancer
; 28(8): 3679-3689, 2020 Aug.
Article
in English
| MEDLINE | ID: mdl-31811481
17.
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells.
Biol Blood Marrow Transplant
; 25(4): 625-638, 2019 04.
Article
in English
| MEDLINE | ID: mdl-30592986
18.
Cytomegalovirus Infection Incidence and Risk Factors Across Diverse Hematopoietic Cell Transplantation Platforms Using a Standardized Monitoring and Treatment Approach: A Comprehensive Evaluation from a Single Institution.
Biol Blood Marrow Transplant
; 25(3): 577-586, 2019 03.
Article
in English
| MEDLINE | ID: mdl-30342913
19.
Ocular Graft-versus-Host Disease after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 25(2): e46-e54, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30481594
20.
Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy.
Biol Blood Marrow Transplant
; 25(12): 2305-2321, 2019 12.
Article
in English
| MEDLINE | ID: mdl-31446199